tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Lava Therapeutics to move Extraordinary General Meeting to early November
PremiumThe FlyLava Therapeutics to move Extraordinary General Meeting to early November
25d ago
Lava Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Lava Therapeutics Reports Q2 2025 Financial Results
2M ago
LAVA Therapeutics Announces Acquisition by XOMA Corporation
Premium
Company Announcements
LAVA Therapeutics Announces Acquisition by XOMA Corporation
2M ago
Xoma to acquire Lava Therapeutics for $1.16-$1.24 per share in cash plus CVR
PremiumThe FlyXoma to acquire Lava Therapeutics for $1.16-$1.24 per share in cash plus CVR
3M ago
Lava Therapeutics’ LAVA-1207 Study Terminated: Implications for Investors
Premium
Company Announcements
Lava Therapeutics’ LAVA-1207 Study Terminated: Implications for Investors
3M ago
LAVA Therapeutics Shareholders Approve Key Proposals in Meeting
Premium
Company Announcements
LAVA Therapeutics Shareholders Approve Key Proposals in Meeting
4M ago
Lava Therapeutics Reports 2024 Financial Results
PremiumCompany AnnouncementsLava Therapeutics Reports 2024 Financial Results
7M ago
Lava Therapeutics reports Q4 EPS (14c) vs. (24c) last year
Premium
The Fly
Lava Therapeutics reports Q4 EPS (14c) vs. (24c) last year
7M ago
Lava Therapeutics sees cash runway into 2027
Premium
The Fly
Lava Therapeutics sees cash runway into 2027
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100